scispace - formally typeset
J

John Q. Trojanowski

Researcher at University of Pennsylvania

Publications -  1538
Citations -  245534

John Q. Trojanowski is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Dementia & Alzheimer's disease. The author has an hindex of 226, co-authored 1467 publications receiving 213948 citations. Previous affiliations of John Q. Trojanowski include Vanderbilt University & University of California, San Francisco.

Papers
More filters
Journal ArticleDOI

Establishment and characterization of the human medulloblastoma cell line and transplantable xenograft D283 Med.

TL;DR: A new continuous cell line and transplantable xenograft, D283 Med, was derived from the peritoneal implant and ascitic fluid of a child with metastatic medulloblastoma and grew in vitro in suspension culture with spontaneous macroscopic spheroid formation.
Journal ArticleDOI

Olfactory epithelium amyloid-beta and paired helical filament-tau pathology in Alzheimer disease.

TL;DR: Olfactory dysfunction is common in Alzheimer disease (AD) and other neurodegenerative diseases andaired helical filament (PHF)‐tau, α‐synuclein, and amyloid‐β lesions occur early and severely in cerebral regions of the olfactory system, and they have also been observed in Olfactory epithelium (OE).
Journal ArticleDOI

Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study

Rita Guerreiro, +78 more
- 01 Jan 2018 - 
TL;DR: Despite the small sample size for a genome-wide association study, and acknowledging the potential biases from ascertaining samples from multiple locations, this study presents the most comprehensive and well powered genetic study in dementia with Lewy bodies so far.
Journal ArticleDOI

Distinct cerebral perfusion patterns in FTLD and AD

TL;DR: Doubly dissociated areas of hypoperfusion in FTLD and AD are consistent with areas of significant histopathologic burden in these groups, suggesting ASL is a potentially useful biomarker for distinguishing patients with these neurodegenerative diseases.